Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Scott Freeze et al.|Journal of Medicinal Chemistry|2021Cited by 205
Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf InhibitorsAlexandra E. Gould, Katherine Galvin, Mansoureh Rezaei et al.|Journal of Medicinal Chemistry|2011Cited by 33
Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERGShih‐Chung Huang, Alexandra E. Gould, M. D. Smith et al.|Bioorganic & Medicinal Chemistry Letters|2016Cited by 10